(Q46439216)

22 December 2017

title

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

1 reference

Grossfeld GD

1

1 reference

22 December 2017

Ginsberg DA

2

1 reference

22 December 2017

Stein JP

3

1 reference

22 December 2017

Bochner BH

4

1 reference

22 December 2017

Esrig D

5

1 reference

22 December 2017

Groshen S

6

1 reference

22 December 2017

Dunn M

7

1 reference

22 December 2017

Nichols PW

8

1 reference

22 December 2017

Taylor CR

9

1 reference

22 December 2017

Skinner DG

10

1 reference

22 December 2017

Cote RJ

11

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

22 December 2017

Journal of the National Cancer Institute

published in

1 reference

22 December 2017

volume

89

1 reference

22 December 2017

page(s)

219-227

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

Thrombospondin as a mediator of cancer cell adhesion in metastasis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Thrombospondin-induced attachment and spreading of human squamous carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Platelet thrombospondin mediates attachment and spreading of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Matrix-bound thrombospondin promotes angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

The region 3' to the major transcriptional start site of the MDR1 downstream promoter mediates activation by a subset of mutant P53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.3.219

21 January 2018

Identifiers

DOI

10.1093/JNCI/89.3.219

1 reference

22 December 2017

PubMed ID

9017002

1 reference

22 December 2017